对注意力缺陷/多动症障碍的药剂师护理电子药物补充:一个集群随机试验
Tracy A Lieu1,2,3, Daniel Parry1,4, Andrew deLaunay5
1The Permanente Medical Group, Pleasanton, CA.
Journal of managed care & specialty pharmacy
|October 31, 2025
概括
药剂师为注意力缺陷/多动症 (ADHD) 药物补充提供高质量的护理,与儿科医生的有效性相匹配. 这项研究表明,药剂师管理确保了持续的质量和及时的ADHD药物补充.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 由于COVID-19大流行,控制物质补充的远程医疗法规放宽了.
- 由于家长要求注意力缺陷/多动症 (ADHD) 药物补充,医生面临着增加的工作量.
- 药剂师可以通过合作实践协议管理ADHD药物补充,但有效性数据有限.
研究的目的:
- 为了比较ADHD药物的质量,及时性和家长满意度,药剂师对儿科医生进行补充管理.
- 为了评估药剂师主导的ADHD治疗疗法的有效性,药物补充.
主要方法:
- 一个集群随机临床试验涉及63个医疗机构分配ADHD药物补充请求到药剂师或儿科医生护理.
- 主要质量结局评估了重量和身高是否在补充前180天内被监测,与服用ADHD药物的儿童临床指南保持一致.
- 数据从2024年5月14日至2024年6月21日收集,比较药剂师和儿科医生管理之间的结果.
主要成果:
- 药剂师管理在88.6%的病例中达到质量指标,而儿科医生管理为66.1% (调整后率比率=1.26).
- 与儿科医生相比,药剂师的处方订购时间略长 (中位数长22分钟),但与儿科医生相比,药物填充时间和家长评级相似.
- 该研究包括2,442个符合条件的补充请求,512人接受药剂师护理,1930人接受儿科医生护理.
结论:
- 与儿科医生管理相比,药剂师对ADHD药物补充的管理导致了更一致的护理质量.
- 处方履行的及时性和家长的满意度在药剂师和儿科医生管理之间是相似的.
- 药剂师领导的协作实践协议为管理ADHD药物补充提供了一个有效的模型,支持医生工作量和患者护理.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.3K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.8K
相关概念视频
Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226
Psychosis: Goals of Pharmacotherapy
434
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
434
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
Mania and Antimanic Drugs: Overview
522
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
522
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
496
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
496
